| Literature DB >> 28384350 |
Haoran Zhang1, Henan Xin1, Xiangwei Li1, Hengjing Li1, Mufei Li1, Wei Lu2, Liqiong Bai3, Xinhua Wang4, Jianmin Liu5, Qi Jin1, Lei Gao1.
Abstract
OBJECTIVES: China has high burden on both of tuberculosis (TB) and tobacco use. This study aims to explore the potential link between smoking and TB infection using baseline survey data of a large-scale population-based prospective study in rural China.Entities:
Mesh:
Year: 2017 PMID: 28384350 PMCID: PMC5383252 DOI: 10.1371/journal.pone.0175183
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the total study population by smoking status.
| Variables | Total | % | Ever-smoker | % | Never-smoker | % | p for χ2 test |
|---|---|---|---|---|---|---|---|
| <0.001 | |||||||
| Male | 9724 | 46.29 | 5061 | 97.42 | 4663 | 29.49 | |
| Female | 11284 | 53.71 | 134 | 2.58 | 11150 | 70.51 | |
| <0.001 | |||||||
| 5–19 | 3556 | 16.93 | 46 | 0.89 | 3510 | 22.20 | |
| 20–29 | 2053 | 9.77 | 514 | 9.89 | 1539 | 10.53 | |
| 30–39 | 2181 | 10.38 | 599 | 11.53 | 1582 | 12.06 | |
| 40–49 | 4648 | 22.12 | 1304 | 25.10 | 3344 | 21.15 | |
| 50–59 | 3612 | 17.19 | 1170 | 22.52 | 2442 | 15.44 | |
| 60–69 | 3136 | 14.93 | 1060 | 20.40 | 2076 | 13.13 | |
| ≥70 | 1822 | 8.67 | 502 | 9.66 | 1320 | 8.35 | |
| Median (inter quartile range) | 46 (27–59) | 50 (41–62) | 44 (23–58) | ||||
| <0.001 | |||||||
| Primary school or lower | 11172 | 53.18 | 2236 | 43.04 | 8936 | 56.51 | |
| Middle school | 6882 | 32.76 | 2198 | 42.31 | 4684 | 29.62 | |
| High school | 2301 | 10.95 | 650 | 12.51 | 1651 | 10.44 | |
| College or higher | 653 | 3.11 | 111 | 2.14 | 542 | 3.43 | |
| <0.001 | |||||||
| <18.5 | 3278 | 15.60 | 278 | 5.35 | 3000 | 18.97 | |
| ≥18.5-<24.0 | 10082 | 47.99 | 2828 | 54.44 | 7254 | 45.88 | |
| ≥24.0-<28.0 | 5596 | 26.64 | 1542 | 29.68 | 4054 | 25.64 | |
| ≥28.0 | 2051 | 9.76 | 547 | 10.53 | 1504 | 9.51 | |
| <0.001 | |||||||
| <6000 | 13411 | 63.84 | 3178 | 61.17 | 10233 | 64.72 | |
| ≥6000 | 7596 | 36.16 | 2017 | 38.83 | 5579 | 35.28 | |
| <0.001 | |||||||
| No | 17017 | 81.01 | 2422 | 46.62 | 14595 | 92.30 | |
| Yes | 3990 | 18.99 | 2773 | 53.38 | 1217 | 7.70 | |
| 0.005 | |||||||
| No | 20185 | 96.12 | 4958 | 95.47 | 15227 | 96.34 | |
| Yes | 814 | 3.88 | 235 | 4.53 | 579 | 3.66 | |
| <0.001 | |||||||
| Yes | 1017 | 4.84 | 350 | 6.74 | 667 | 4.22 | |
| No | 19911 | 95.16 | 4845 | 93.26 | 15146 | 95.78 | |
| <0.001 | |||||||
| Positive | 3954 | 18.82 | 1468 | 28.26 | 2486 | 15.72 | |
| Negative | 16454 | 78.32 | 3624 | 69.76 | 12830 | 81.14 | |
| Indeterminate | 600 | 2.86 | 103 | 1.98 | 497 | 3.14 |
Abbreviations: BMI = body mass index; IQR = interquartile range; QFT = QuantiFERON-TB Gold In-Tube; T2DM = type 2 diabetes mellitus; TB = tuberculosis.
†Sum might not always be in total because of missing data. Frequency of missing data did not differ significantly between smoking statuses.
‡ P values refer to the comparison of different variables between ever- and never-smokers.
Identification of the factors independently associated with QFT positivity in the total study population.
| Variables | QFT positivity(n/N | % | p for χ2 test | Adjusted OR |
|---|---|---|---|---|
| Female | 1832/10863 | 16.86 | <0.001 | Reference |
| Male | 2122/9545 | 22.23 | 1.26 (1.14, 1.39) | |
| 5–19 | 100/3485 | 2.87 | <0.001 | Reference |
| 20–29 | 175/2009 | 8.71 | 2.72 (2.07, 3.56) | |
| 30–39 | 313/2114 | 14.81 | 4.83 (3.73, 6.25) | |
| 40–49 | 876/4510 | 19.42 | 6.64 (5.22, 8.45) | |
| 50–59 | 934/3478 | 26.85 | 9.97 (7.83, 12.69) | |
| 60–69 | 966/3047 | 31.70 | 12.65 (9.95, 16.07) | |
| ≥70 | 590/1765 | 33.43 | 14.27 (11.19, 18.21) | |
| Primary school or lower | 2236/10796 | 20.71 | <0.001 | |
| Middle school | 1275/6714 | 18.99 | ||
| High school | 375/2259 | 16.60 | ||
| College or higher | 68/639 | 10.64 | ||
| <6000 | 2512/12978 | 19.36 | 0.924 | |
| ≥6000 | 1442/7429 | 19.41 | ||
| <18.5 | 230/3203 | 7.18 | <0.001 | 0.86 (0.73, 1.02) |
| ≥18.5-<24.0 | 2002/9762 | 20.51 | Reference | |
| ≥24.0-<28.0 | 1257/5444 | 23.09 | 1.06 (0.98, 1.16) | |
| ≥28.0 | 465/1998 | 23.27 | 1.15 (1.02, 1.29) | |
| Never smoked | 2486/15316 | 16.23 | <0.001 | Reference |
| Ever smoked | 1468/5092 | 28.83 | 1.34 (1.21, 1.49) | |
| No | 2957/16486 | 17.94 | <0.001 | |
| Yes | 997/3921 | 25.21 | ||
| No | 3722/19618 | 18.97 | <0.001 | Reference |
| Yes | 231/781 | 29.58 | 1.62 (1.37, 1.90) | |
| No | 3689/19427 | 18.99 | <0.001 | |
| Yes | 265/981 | 27.01 |
Abbreviations: BMI = body mass index; CI = confidence interval; OR = odds ratio; QFT = QuantiFERON-TB Gold In-Tube; T2DM = type 2 diabetes mellitus; TB = tuberculosis.
† Participants with indeterminate results were not included in this analysis. Sum might not always be in total because of missing data.
# Adjusted for variables with p < 0.05 in univariate analysis by stepwise selection. Sex and age kept in the model.
Fig 1Distribution of QFT positivity among ever-smokers and never-smokers by smoking status, gender (1A) and age (1B). After classified by gender and age groups, ever-smokers were still more likely to be QFT positivity than never-smokers (*: p < 0.05, **: p < 0.01). Abbreviations: QFT = QuantiFERON-TB Gold In-Tube.
Association analysis for QFT positivity among smokers.
| Variables | N | % | p for χ2 test | Adjusted OR |
|---|---|---|---|---|
| Female | 41/131 | 31.30 | 0.528 | Reference |
| Male | 1427/4961 | 28.76 | 0.91 (0.62.1.35) | |
| 5–19 | 4/46 | 8.70 | <0.001 | Reference |
| 20–29 | 58/506 | 11.46 | 1.30 (0.45,3.75) | |
| 30–39 | 108/590 | 18.31 | 1.72 (0.58,5.09) | |
| 40–49 | 331/1285 | 25.76 | 2.27 (0.76,6.72) | |
| 50–59 | 367/1139 | 32.22 | 2.74 (0.91,8.19) | |
| 60–69 | 394/1033 | 38.14 | 3.25 (1.08,9.79) | |
| ≥70 | 206/493 | 41.78 | 3.53 (1.15, 10.85) | |
| Primary school or lower | 731/2179 | 33.55 | <0.001 | |
| Middle school | 560/2162 | 25.90 | ||
| High school | 155/643 | 24.11 | ||
| College or higher | 22/108 | 20.37 | ||
| <6000 | 924/3108 | 29.74 | 0.076 | |
| ≥6000 | 544/1984 | 27.42 | ||
| 18.5–24.0 | 814/2766 | 29.43 | 0.520 | |
| <18.5 | 71/276 | 25.72 | ||
| 24.0–28.0 | 436/1515 | 28.78 | ||
| ≥28.0 | 147/535 | 27.48 | ||
| No | 732/2358 | 31.04 | 0.001 | |
| Yes | 736/2734 | 26.92 | ||
| No | 1381/4862 | 28.40 | 0.002 | Reference |
| Yes | 87/228 | 38.16 | 1.48 (1.12,1.97) | |
| No | 1352/4751 | 28.46 | 0.029 | |
| Yes | 116/341 | 34.02 | ||
| Former smoker | 101/352 | 28.69 | 0.953 | |
| Current smoker | 1367/4740 | 28.84 | ||
| Without filter | 108/324 | 33.33 | 0.064 | |
| With filter | 1360/4768 | 28.52 | ||
| <18 | 279/927 | 30.10 | 0.346 | |
| ≥18 | 1189/4165 | 28.55 | ||
| ≤10 | 96/753 | 12.75 | <0.001 | Reference |
| 10–20 | 199/891 | 22.33 | p for trend<0.001 | 1.45 (1.02, 2.06) |
| 20–30 | 366/1305 | 28.05 | 1.65 (1.14, 2.40) | |
| 30–40 | 392/1138 | 34.45 | 1.90(1.28, 2.82) | |
| 40–50 | 294/726 | 40.50 | 2.09 (1.36, 3.19) | |
| >50 | 121/279 | 43.37 | 2.26 (1.38, 3.69) | |
| 1–5 | 126/507 | 24.85 | 0.009 | |
| 5–10 | 182/683 | 26.65 | p for trend<0.001 | |
| 10–19 | 525/1912 | 27.46 | ||
| ≥20 | 635/1990 | 31.91 |
Abbreviations: BMI = body mass index; CI = confidence interval; OR = odds ratio; QFT = QuantiFERON-TB Gold In-Tube; T2DM = type 2 diabetes mellitus; TB = tuberculosis.
† Indeterminate results had been excluded from the analysis. Sum might not always be in total because of missing data.
# Adjusted for variables with p < 0.05 in univariate analysis by stepwise selection. Sex and age kept in the model.
Fig 2Association of QFT positivity with smoking years among smokers.
Multiple logistic regression analysis was conducted to assess the association of smoking years with QFT positivity. Variables with p < 0.05 in univariate analysis were included in the model. Gender, age, education level, history of close contact with tuberculosis patients, alcohol drinking, number of cigarettes smoked per day were adjusted. Adjusted odds ratio (ORs) and the 95% confidence intervals (CIs) were given in the figure. Abbreviations: CI = confidence interval; QFT = QuantiFERON-TB Gold In-Tube.
The association of QFT positivity and smoking status by age, gender and TB contact history among total study populations.
| Variables | QFT positivity (n/N) | % | Adjusted OR (95%CI) | |
|---|---|---|---|---|
| Female | Never-smoker | 1791/10732 | 16.69 | Reference |
| Ever-smoker | 41/131 | 31.30 | 1.70 (1.16, 2.50) | |
| Male | Never-smoker | 695/4584 | 15.16 | Reference |
| Ever-smoker | 1427/4961 | 28.76 | 1.45 (1.30, 1.61) | |
| p for likelihood ratio test | 0.842 | |||
| 5–19 years | Never-smoker | 96/3439 | 2.79 | Reference |
| Ever-smoker | 4/46 | 8.70 | 3.44 (1.16, 10.16) | |
| 20–39 years | Never-smoker | 322/3027 | 10.64 | Reference |
| Ever-smoker | 166/1096 | 15.15 | 1.40 (1.07, 1.85) | |
| 40–59 years | Never-smoker | 1112/5564 | 19.99 | Reference |
| Ever-smoker | 698/2424 | 28.80 | 1.32 (1.13, 1.55) | |
| ≥ 60 years | Never-smoker | 956/3286 | 29.09 | Reference |
| Ever-smoker | 600/1526 | 39.32 | 1.31 (1.10,1.55) | |
| p for likelihood ratio test | 0.002 | |||
| No | Never-smoker | 2341/14756 | 15.86 | Reference |
| Ever-smoker | 1381/4862 | 28.40 | 1.49 (1.34, 1.66) | |
| Yes | Never-smoker | 144/553 | 26.04 | Reference |
| Ever-smoker | 87/228 | 38.16 | 1.32 (0.84, 2.06) | |
| p for likelihood ratio test | 0.931 | |||
| <28.0(kg/m2) | Never-smoker | 2168/13853 | 15.65 | Reference |
| Ever-smoker | 1321/4557 | 28.99 | 1.47 (1.32, 1.97) | |
| ≥28.0 (kg/m2) | Never-smoker | 318/1463 | 21.74 | Reference |
| Ever-smoker | 147/535 | 27.48 | 1.55 (1.11, 2.15) | |
| p for likelihood ratio test | 0.838 | |||
Abbreviations: BMI = Body mass index; CI = confidence interval; OR = odds ratio; QFT = QuantiFERON-TB Gold In-Tube; TB = tuberculosis. Participants with indeterminate results were not included in this analysis. Sum might not always be in total because of missing data.
& Variables independently associated with QFT positivity identified in Table 2 were considered in this analysis.
†Adjusted for age, BMI and TB contact history.
‡ Adjusted for gender, BMI and TB contact history.
Adjusted for age, BMI and gender.
Adjusted for age, TB contact history and gender.